These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34212840)

  • 1. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
    Tran Kiem C; Andronico A; Bosetti P; Paireau J; Alter L; Boëlle PY; Fontanet A; Lévy-Bruhl D; Cauchemez S
    Euro Surveill; 2021 Jul; 26(26):. PubMed ID: 34212840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
    Lau CL; Mayfield HJ; Sinclair JE; Brown SJ; Waller M; Enjeti AK; Baird A; Short KR; Mengersen K; Litt J
    Vaccine; 2021 Dec; 39(51):7429-7440. PubMed ID: 34810000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data.
    Lane S; Shakir S
    Drug Saf; 2022 Sep; 45(9):1003-1008. PubMed ID: 35927605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
    Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
    Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states.
    Buhl C; Jacobsen R; Almarsdóttir AB; Abtahi S; Andersen A; Deligianni E; Dermiki-Gkana F; Kontogiorgis C; Oikonomou C; Kursite M; Poplavska E; Hegger I; van der Goot M; Sousa Ferreira PB; Ribeiro-Vaz I; Silva AM; Kos M; Lipovec NČ; van Vliet E; Alves TL
    Vaccine; 2024 Jan; 42(3):556-563. PubMed ID: 38182460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19].
    Wolthers SA; Stenberg J; Nielsen HB; Stensballe J; Pedersen HP
    Ugeskr Laeger; 2021 Aug; 183(35):. PubMed ID: 34477089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: A perspective from social pharmacology.
    Montastruc JL; Lafaurie M; de Canecaude C; Montastruc F; Bagheri H; Durrieu G; Sommet A
    Therapie; 2021; 76(4):311-315. PubMed ID: 34119317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021.
    Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Guevara M; Fernández-Huerta M; Burgui C; Casado I; Portillo ME; Navascués A; Ezpeleta C; Castilla J; ;
    Euro Surveill; 2021 Sep; 26(39):. PubMed ID: 34596016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.
    Faranda D; Alberti T; Arutkin M; Lembo V; Lucarini V
    Chaos; 2021 Apr; 31(4):041105. PubMed ID: 34251248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST).
    Suresh P; Petchey W
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34135077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
    Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
    Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Covid-19 vaccination and renal patients: overcoming unwarranted fears and re-establishing priorities].
    Sciarrone Alibrandi MT; Vespa M; Joli G; Bucci R; Brioni E; Rivera RF
    G Ital Nefrol; 2021 Apr; 38(2):. PubMed ID: 33852219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks.
    Chavan M; Qureshi H; Karnati S; Kollikonda S
    J Obstet Gynaecol Can; 2021 Jul; 43(7):814-816. PubMed ID: 34253304
    [No Abstract]   [Full Text] [Related]  

  • 16. [COVID-19 - The vaccine miracle must include strictness and caution].
    Agut H
    Virologie (Montrouge); 2021 Jun; 25(3):141-147. PubMed ID: 34112629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How could a COVID vaccine cause blood clots? Scientists race to investigate.
    Ledford H
    Nature; 2021 Apr; 592(7854):334-335. PubMed ID: 33846607
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
    Mateo-Urdiales A; Spila Alegiani S; Fabiani M; Pezzotti P; Filia A; Massari M; Riccardo F; Tallon M; Proietti V; Del Manso M; Puopolo M; Spuri M; Morciano C; D'Ancona FP; Da Cas R; Battilomo S; Bella A; Menniti-Ippolito F; ;
    Euro Surveill; 2021 Jun; 26(25):. PubMed ID: 34169819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue.
    Ward JK; Alleaume C; Peretti-Watel P;
    Soc Sci Med; 2020 Nov; 265():113414. PubMed ID: 33038683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an interactive web tool on patients' intention to receive COVID-19 vaccination: a before-and-after impact study among patients with chronic conditions in France.
    Tran VT; Sidorkiewicz S; Péan C; Ravaud P
    BMC Med Inform Decis Mak; 2021 Jul; 21(1):228. PubMed ID: 34332570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.